MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. Gene Biodesign has been certified to process customer samples in their laboratory in northern Taipei county for NimbleGen array applications including Comparative Genomic Hybridization (CGH), Chromatin Immunoprecipitation-on-chip (ChIP-chip), DNA Methylation and Gene Expression. Gene Biodesign passed rigorous certification standards using the Roche NimbleGen workflow, which includes the 2 micron NimbleGen MS 200 Microarray Scanner. Gene Biodesign will provide NimbleGen array services at their location in the Mackay Memorial Hospital, a teaching hospital responsible for the clinical training of interns in modern medical studies and clinical care. The collaborative atmosphere between clinicians and genomics researchers will provide a broad perspective on their studies.
